Cutler Group’s Quest Diagnostics DGX Stock Holding History

Cutler Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,500	Closed	-$4K	–	3963
2022 Q4	$4K	Buy	+2,500	New	+$359K	﹤0.01%	3278
2022 Q2	–	Sell	-4,200	Closed	-$4K	–	5096
2022 Q1	$4K	Buy	+4,200	New	+$585K	﹤0.01%	4247
2021 Q4	–	Sell	-10,400	Closed	-$28K	–	5483
2021 Q3	$28K	Hold	10,400	–	–	﹤0.01%	3028
2021 Q2	$13K	Buy	+10,400	New	+$1.36M	﹤0.01%	3668
2019 Q4	–	Sell	-7,700	Closed	-$33K	–	4081
2019 Q3	$33K	Sell	7,700 -3,100	-29%	-$318K	﹤0.01%	1819
2019 Q2	$28K	Buy	+10,800	New	+$1.04M	﹤0.01%	1958
2017 Q4	–	Sell	-10,000	Closed	-$9K	–	5077
2017 Q3	$9K	Buy	+10,000	New	+$1.06M	﹤0.01%	3877
2017 Q1	–	Sell	-31,800	Closed	-$196K	–	6516
2016 Q4	$196K	Buy	31,800 +28,200	+783%	+$2.43M	0.01%	1310
2016 Q3	$7K	Sell	3,600 -1,000	-22%	-$84K	﹤0.01%	4579
2016 Q2	$14K	Buy	+4,600	New	+$350K	﹤0.01%	3745
2016 Q1	–	Sell	-16,200	Closed	-$7K	–	6609
2015 Q4	$7K	Buy	+16,200	New	+$1.09M	﹤0.01%	4525

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cutler Group's DGX Position: Q1 2023 in Review

Cutler Group sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 1,298 shares — an estimated $203K sold.

Cutler Group first reported a position in DGX in Q4 2015 and held it in 11 quarters. The position peaked at $538K in Q3 2017. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

Cutler Group reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
Cutler Group sold 1,298 Quest Diagnostics shares in Q1 2023, an estimated $203K.
Cutler Group first reported a position in Quest Diagnostics in Q4 2015 and held it in 11 quarters.
Cutler Group's Quest Diagnostics position peaked at $538K in Q3 2017.
834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.